AI assistant
908 Devices Inc. — Director's Dealing 2021
Sep 10, 2021
33342_dirs_2021-09-10_b369cd11-e2dd-499b-a6fb-5503f1171abd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: 908 Devices Inc. (MASS)
CIK: 0001555279
Period of Report: 2021-09-09
Reporting Person: Turner Michael S. (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-09-09 | Common Stock, par value $0.001 | M | 21848.00 | $7.91 | Acquired | 26848.00 | Direct |
| 2021-09-09 | Common Stock, par value $0.001 | S | 14952.00 | $36.12 | Disposed | 11896.00 | Direct |
| 2021-09-09 | Common Stock, par value $0.001 | S | 6896.00 | $37.05 | Disposed | 5000.00 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-09-09 | Stock Option (option to buy) | $7.91 | M | 21848.00 | Disposed | 2030-11-03 | Common Stock, par value $0.001 (122918.00) | Direct |
Footnotes
F1: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.78 to $36.73, inclusive. The reporting person undertakes to provide to 908 Devices Inc., any security holder of 908 Devices Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.78 to $37.59, inclusive. The reporting person undertakes to provide to 908 Devices Inc., any security holder of 908 Devices Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F4: The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 48 months following November 2, 2020, subject to the reporting person's continued service through the applicable vesting date.